Palvella Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Wayne, PA
PVLA chart
What traders are saying about $PVLA
Latest postsPalvella Therapeutics, Inc. news
- Canaccord Genuity maintains Palvella Therapeutics at Buy, raises price target to $243 from $232
TradingView ·
- A Quick Look at Today's Ratings for Palvella Therapeutics(PVLA.US), With a Forecast Between $207 to $246
Moomoo ·
- Palvella Therapeutics, Inc. (PVLA) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Oppenheimer maintains Palvella Therapeutics at Outperform, raises price target to $232 from $210
TradingView ·
- Oppenheimer Adjusts Palvella Therapeutics Price Target to $232 From $210, Maintains Outperform Rating
www.marketscreener.com ·
- Palvella Therapeutics Inc (PVLA) (Q3 2026) Earnings Call Highlights: FDA Priority Review, $236. ...
Yahoo Finance ·
- Palvella Therapeutics, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- What Palvella Therapeutics (PVLA) Said on Its Q3 Earnings Call
marketbeat.com ·
- Palvella (PVLA) Q3 2026 Earnings Call Transcript
fool.com ·
- Palvella Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Earnings Flash (PVLA) Palvella Therapeutics Posts Q3 Loss $1.70 a Share
www.marketscreener.com ·
- Palvella Therapeutics Inc. R (PI6.F) Q3 FY2026 earnings call transcript
Yahoo Finance ·
Palvella Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $42.8M | $25.9M |
| Net income | -$41.7M | -$17.4M | $18.7M | -$33.3M |
| Diluted EPS | $-3.71 | $-7.83 | $2.17 | – |
| Total assets (year end) | $59.6M | $88.2M | $7.5M | $95.5M |
| Cash and equivalents (year end) | $58.0M | $83.6M | $7.3M | $38.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Palvella Therapeutics, Inc.
- Ticker
- PVLA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wayne, PA
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1583648
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
Frequently asked questions
What exchange is Palvella Therapeutics, Inc. listed on?
Palvella Therapeutics, Inc. trades on the Nasdaq under the ticker symbol PVLA.
What industry is Palvella Therapeutics, Inc. in?
Palvella Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Palvella Therapeutics, Inc. headquartered?
Palvella Therapeutics, Inc.'s business address on file with the SEC is in Wayne, PA.
When does Palvella Therapeutics, Inc.'s fiscal year end?
Palvella Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Palvella Therapeutics, Inc. report?
Palvella Therapeutics, Inc. reported $42.8M in revenue for calendar year 2023, according to its SEC filings.